158 related articles for article (PubMed ID: 9434158)
1. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
[TBL] [Abstract][Full Text] [Related]
2. Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin.
Kang MR; Muller MT; Chung IK
J Biol Chem; 2004 Mar; 279(13):12535-41. PubMed ID: 14729676
[TBL] [Abstract][Full Text] [Related]
3. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.
Lee CC; Huang TS
Pharm Res; 2001 Jun; 18(6):846-51. PubMed ID: 11474790
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
Nahon E; Best-Belpomme M; Saucier JM
Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480
[TBL] [Abstract][Full Text] [Related]
5. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
[TBL] [Abstract][Full Text] [Related]
6. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
Bandele OJ; Osheroff N
Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
Kingma PS; Greider CA; Osheroff N
Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats.
Spitzner JR; Chung IK; Muller MT
Nucleic Acids Res; 1990 Jan; 18(1):1-11. PubMed ID: 2155393
[TBL] [Abstract][Full Text] [Related]
10. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
Ritke MK; Allan WP; Fattman C; Gunduz NN; Yalowich JC
Mol Pharmacol; 1994 Jul; 46(1):58-66. PubMed ID: 8058057
[TBL] [Abstract][Full Text] [Related]
11. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
12. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
13. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
Wilstermann AM; Osheroff N
Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.
Weissig V; Vetro-Widenhouse TS; Rowe TC
DNA Cell Biol; 1997 Dec; 16(12):1483-92. PubMed ID: 9428797
[TBL] [Abstract][Full Text] [Related]
16. Apurinic sites are position-specific topoisomerase II poisons.
Kingma PS; Osheroff N
J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
[TBL] [Abstract][Full Text] [Related]
17. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
Borgnetto ME; Tinelli S; Carminati L; Capranico G
J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
[TBL] [Abstract][Full Text] [Related]
18. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
[TBL] [Abstract][Full Text] [Related]
19. Evidence on the chromosomal location of centromeric DNA in Plasmodium falciparum from etoposide-mediated topoisomerase-II cleavage.
Kelly JM; McRobert L; Baker DA
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6706-11. PubMed ID: 16617116
[TBL] [Abstract][Full Text] [Related]
20. The role of telomeres in Etoposide induced tumor cell death.
Jeyapalan J; Leake A; Ahmed S; Saretzki G; Tilby M; von Zglinicki T
Cell Cycle; 2004 Sep; 3(9):1169-76. PubMed ID: 15326395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
